STAT

Opinion: Stem cell clinics for heart failure: buyer be wary

Patients are turning to so-called stem cell clinics that offer treatments that will supposedly reverse heart failure. They can't be sure what they are getting.
Embryonic stem cells as seen through a microscope.

We are witnessing great promise in medicine today. The vocabulary dazzles: “precision medicine,” “stem cells,” “moon shot,” and other terms that hint at exciting new possibilities. But it is also a time of great vulnerability for patients.

I’m particularly worried about stem cells or, more precisely, stem cell therapies. In theory, stem cells could help treat — or even cure — conditions ranging from cancer to heart failure. As a cardiologist, I’m especially interested in their application to the latter condition. Even though the hype far exceeds the evidence, patients are already turning to so-called stem cell clinics that claim to reverse heart failure.

So-called “pluripotential” stem cells have the ability to develop

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks